Primary Myelofibrosis Not Yet Recruiting Phase 2 Trials for Selinexor (DB11942)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03627403Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 InhibitorsTreatment